ConforMIS lured Zimmer’s dental business operations director, Matthew Scott, away to be its new chief operating officer as it looks to scale up its customized knee implant business.
The Bedford, Mass.-based medical device company said Scott bring’s a decade’s worth of ops experience from his tenure at Zimmer. ConforMIS makes knee replacement implants and instrumentation that are custom-fit to patients’ morphology.
"Matthew’s leadership will be integral in scaling up manufacturing to keep up with growth, but also in reengineering our operations to take full advantage of the patient-specific, just-in-time nature of our approach," founder & CEO Dr. Phillip Lang said in prepared remarks.
Scott’s resume includes his most-recent stint as director of operations for Zimmer Dental, where he oversaw all aspects and "managed the rapid growth of the dental implant manufacturing facilities," according to a press release. He also worked for Zimmer’s orthopedics arm, starting out as production manager for the Warsaw, Ind.-based device giant’s knee femoral business, according to the release.
"His deep familiarity with the production technologies used in orthopedics led to leadership roles on teams responsible for lean process redesign, cost efficiencies, and technology transfer," ConforMIS said. "Mr. Scott was also responsible for helping establish a global network of manufacturing facilities to support the hip and knee implant business. He developed the business case for several overseas facilities, planned and executed the build out of the sites, and served as interim general manager of a new production facility in Ireland before moving to Zimmer Dental."
Orthofix EVP Trelles is out
Orthofix (NSDQ:OFIX) said it decided not to renew its employment agreement with executive vice president of worldwide operations & shared services, which was set to expire July 1. In return for agreeing to $479,000 in severance benefits and legal expense reimbursements and some health & dental benefits, Trelles agreed to be on call through June 30 to assist with the transition, Orthofix said.
Cerapedics names Biomet vet Kashuba as its new CEO
Cerapedics tapped Glen Kashuba, formerly worldwide president of Biomet subsidiary Spine & Bone Healing Technologies, to its CEO effective June 1. Cerapedics raised a $19 million Series C round in December 2012.
Harvard Bioscience CEO Graziano retires
Harvard Bioscience (NSDQ:HBIO) promoted president David Green to be its interim CEO upon the YY retirement of 17-year CEO Chane Graziano, 74. Harvard Bioscience said its board is immediately launching the search for a replacement.
Ex-Novartis CEO Watson joins Wright Medical’s board
Wright Medical (NSDQ:WMGI) said Douglas Watson, the former president & CEO of pharma giant Novartis (NYSE:NVS), was named to its board, taking the number of directors to 10.